- Home
- RPTX vs PDSB Comparison
RPTX vs PDSB Comparison
Compare RPTX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- PDSB
- Stock Information
- Founded
- RPTX 2016
- PDSB 2005
- Country
- RPTX Canada
- PDSB United States
- Employees
- RPTX N/A
- PDSB N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- RPTX Health Care
- PDSB Health Care
- Exchange
- RPTX Nasdaq
- PDSB Nasdaq
- Market Cap
- RPTX 64.8M
- PDSB 72.2M
- IPO Year
- RPTX 2020
- PDSB N/A
- Fundamental
- Price
- RPTX $1.57
- PDSB $1.19
- Analyst Decision
- RPTX Strong Buy
- PDSB Strong Buy
- Analyst Count
- RPTX 3
- PDSB 2
- Target Price
- RPTX $4.50
- PDSB $10.00
- AVG Volume (30 Days)
- RPTX 112.2K
- PDSB 346.9K
- Earning Date
- RPTX 08-08-2025
- PDSB 08-13-2025
- Dividend Yield
- RPTX N/A
- PDSB N/A
- EPS Growth
- RPTX N/A
- PDSB N/A
- EPS
- RPTX N/A
- PDSB N/A
- Revenue
- RPTX $250,000.00
- PDSB N/A
- Revenue This Year
- RPTX N/A
- PDSB N/A
- Revenue Next Year
- RPTX N/A
- PDSB N/A
- P/E Ratio
- RPTX N/A
- PDSB N/A
- Revenue Growth
- RPTX N/A
- PDSB N/A
- 52 Week Low
- RPTX $0.89
- PDSB $0.85
- 52 Week High
- RPTX $4.07
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- RPTX 57.39
- PDSB 49.72
- Support Level
- RPTX $1.54
- PDSB $1.13
- Resistance Level
- RPTX $1.60
- PDSB $1.32
- Average True Range (ATR)
- RPTX 0.05
- PDSB 0.08
- MACD
- RPTX 0.00
- PDSB 0.02
- Stochastic Oscillator
- RPTX 75.00
- PDSB 56.67
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.